Announcement by Map Medical (301033.SZ): the board of directors of the company believes that the grant conditions stipulated in the Draft Restricted Stock Incentive Plan of Guangzhou Map Regenerative Medical Technology Co., Ltd. in 2024 have been met, and agrees to set July 16, 2024 as the first grant date of the incentive plan. It will grant 0.461 million restricted stocks to 28 qualified incentive objects at a first grant price of 22.80 yuan per share.
According to the announcement of Map Medical (301033.SZ) on the Zhitong Financial APP, the board of directors of the company believes that the grant conditions stipulated in the Draft Restricted Stock Incentive Plan of Guangzhou Map Regenerative Medical Technology Co., Ltd. in 2024 have been met, and agrees to set July 16, 2024 as the first grant date of the incentive plan. It will grant 0.461 million restricted stocks to 28 qualified incentive objects at a first grant price of 22.80 yuan per share.